SICOM India LimitedUnlisted Shares
₹ 85▲0.00%(0.00)
About the company
SICOM Limited (State Industrial & Investment Corporation of Maharashtra) is a well-established Non-Banking Financial Company (NBFC) that has played a significant role in supporting industrial and economic development in India. Established in 1966 by the Government of Maharashtra and later privatized in 1995, the company has decades of experience in providing financial and advisory services to businesses across a wide range of industries.
Headquartered in Mumbai, with regional offices in Pune, Aurangabad, Nashik, Nagpur, and New Delhi, SICOM has built a strong presence by assisting businesses with funding, strategic guidance, and project development. Over the years, the company has supported the growth of more than 3,000 industrial units, contributing to large-scale investments and helping businesses expand across manufacturing, infrastructure, information technology, and other key sectors.
Fundamentals
Valuation
- 52 week high
- —
- 52 week low
- —
- P/B ratio
- 0
- ROE (%)
- N/A
- Book value
- N/A
- Face value
- ₹10
- Valuation
- —
Registry
- ISIN number
- INE569E01018
Leadership
| Name | Role | Experience | |
|---|---|---|---|
| Dr Nitin Jawale | Managing Director | 30+ yrs experience | — |
| Dr Harshadeep Shriram Kamble | Director | 30+ yrs experience | — |
| Nitin Mahajan | CFO | 25+ yrs experience | — |
Frequently asked questions
Common questions on SICOM India Limited Unlisted Shares—tap a row to read the answer.
Q.1What is SICOM Limited?
SICOM Limited is a Non-Banking Financial Company (NBFC) that provides financial and advisory solutions to businesses across industries such as manufacturing, infrastructure, information technology, and services. The company offers a wide range of services, including business loans, equipment financing, leasing, corporate advisory, and project financing, helping businesses meet their growth and expansion needs.
Q.2Can I invest in SICOM Limited unlisted shares?
Yes, if SICOM Limited unlisted shares are available in the private market, eligible investors can purchase them through private share transactions. Since the company is not listed on a recognized stock exchange, share availability depends on existing shareholders willing to sell and prevailing market demand.
Q.3How can I buy SICOM Limited unlisted shares?
You can buy SICOM Limited unlisted shares through authorized intermediaries that facilitate private market transactions. Once the share price, quantity, and required documentation are finalized, the shares are transferred electronically to your Demat account after the transaction is successfully completed.
Q.4How is the price of SICOM Limited unlisted shares determined?
The price of SICOM Limited unlisted shares is generally influenced by several factors, including the company's financial performance, net worth, business outlook, loan portfolio, profitability, recent private market transactions, investor demand, and overall market conditions. Since the shares are not traded on a stock exchange, their value is determined through private negotiations.
Q.5Is it legal to buy SICOM Limited unlisted shares in India?
Yes. Buying and selling unlisted shares is legal in India when the transaction is carried out in accordance with applicable laws and regulatory guidelines. Investors should ensure that the shares are transferred through a valid process with proper documentation and credited to their Demat account.
Q.6Do I need a Demat account to hold SICOM Limited unlisted shares?
Yes. An active Demat account is generally required to receive and hold SICOM Limited unlisted shares in electronic form. Holding shares in a Demat account ensures secure ownership and simplifies future transfers or sales.
Trending shares
High-demand unlisted opportunities currently available for trade.
From the blog
Notes on unlisted markets, execution hygiene, and how we think about risk—no hype, no ticker spam.

APTUS PHARMA IPO
Aptus Pharma Limited rolled out its 100% book-built BSE SME public offering worth ₹13.02 Crore. Review crucial parameters for retail investors, featuring the ₹65–₹70 price band, working capital allocations, and an evaluation of its contract-manufacturing partner model.

NEPHROPLUS (NEPHROCARE HEALTH SERVICES) IPO
Explore the Neochem Bio IPO, including issue details, business strengths, risks, and investment analysis.

APOLLO TECHNO INDUSTRIES IPO
Apollo Techno Industries Limited has announced its public offering details. Explore the essential investment parameters for retail and institutional bidders, highlighting the fixed price band, lot structure, key market deadlines, and an overview of its industrial manufacturing footprint.

NEOCHEM BIO IPO
Explore the Neochem Bio IPO, including issue details, business strengths, risks, and investment analysis.

ANONDITA MEDICARE IPO
Anondita Medicare Limited rolled out its 100% book-built SME public offering worth ₹69.50 Crore on the NSE SME platform. Dig into the critical parameters for investors, highlighting the ₹137–₹145 price band, key working capital objectives, and an analysis of its flagship brand 'COBRA' within the growing sexual wellness market.

NEPTUNE LOGITEK IPO
Explore the Neptune Logitek IPO, including issue details, business strengths, risks, and investment analysis.
